Daniel Perry

Daniel Perry currently serves as Associate Director and Principal Scientist at Century Therapeutics, Inc., where leadership of research activities within the Immunology team focuses on developing novel iPSC-derived T cell therapies aimed at creating "off-the-shelf" solutions for cancer treatment. Prior experience includes roles as Assistant Research Scientist, Postdoctoral Associate, and Graduate Research Associate at the University of Florida, where research work covered autoimmune susceptibility in human T cells and genetic determinants of Systemic Lupus Erythematosus. Educational background includes a Ph.D. in Biomedical Sciences from the University of Florida and a B.S. in Animal Sciences from the University of Vermont.